Your search returned 8 results.

Results
	1.	Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis: a retrospective evaluation using Medicare claims. [electronic resource] by Weycker, Derek Hanau, Ahuva Lonshteyn, Alexander Bowers, Charles Garawin, Tamer Bensink, Mark Chandler, David Producer: 20200310 In: Current medical research and opinion vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice. [electronic resource] by Weycker, Derek Hatfield, Mark Grossman, Aaron Hanau, Ahuva Lonshteyn, Alex Sharma, Anjali Chandler, David Producer: 20190625 In: BMC cancer vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Risk of chemotherapy-induced febrile neutropenia with same-day versus next-day pegfilgrastim prophylaxis among patients aged ≥65 years: a retrospective evaluation using Medicare claims. [electronic resource] by Weycker, Derek Hanau, Ahuva Lonshteyn, Alexander Bowers, Charles Bensink, Mark Garawin, Tamer Chandler, David Producer: 20191004 In: Current medical research and opinion vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosis. [electronic resource] by Weycker, Derek Hanau, Ahuva Hatfield, Mark Wu, Hongsheng Sharma, Anjali Bensink, Mark E Chandler, David Grossman, Aaron Tarantino, Michael Producer: 20201116 In: Journal of medical economics vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Use and effectiveness of pegfilgrastim prophylaxis in US clinical practice:a retrospective observational study. [electronic resource] by Weycker, Derek Doroff, Robin Hanau, Ahuva Bowers, Charles Belani, Rajesh Chandler, David Lonshteyn, Alexander Bensink, Mark Lyman, Gary H Producer: 20200109 In: BMC cancer vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Bleeding and recurrent VTE with apixaban vs warfarin as outpatient treatment: time-course and subgroup analyses. [electronic resource] by Weycker, Derek Wygant, Gail DeVecchis Guo, Jennifer D Lee, Theodore Luo, Xuemei Rosenblatt, Lisa Mardekian, Jack Atwood, Mark Hanau, Ahuva Cohen, Alexander T Producer: 20200720 In: Blood advances vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice. [electronic resource] by Weycker, Derek Li, Xiaoyan Wygant, Gail DeVecchis Lee, Theodore Hamilton, Melissa Luo, Xuemei Vo, Lien Mardekian, Jack Pan, Xianying Burns, Leah Atwood, Mark Hanau, Ahuva Cohen, Alexander T Producer: 20190111 In: Thrombosis and haemostasis vol. 118 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Erratum: Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice. [electronic resource] by Weycker, Derek Li, Xiaoyan Wygant, Gail DeVecchis Lee, Theodore Hamilton, Melissa Luo, Xuemei Vo, Lien Mardekian, Jack Pan, Xianying Burns, Leah Atwood, Mark Hanau, Ahuva Cohen, Alexander T Publication details: Thrombosis and haemostasis 11 2018 In: Thrombosis and haemostasis vol. 118 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)